These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22291657)

  • 1. Brain Renin-Angiotensin system in hypertension, cardiac hypertrophy, and heart failure.
    Campos LA; Bader M; Baltatu OC
    Front Physiol; 2011; 2():115. PubMed ID: 22291657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications.
    Miller AJ; Arnold AC
    Clin Auton Res; 2019 Apr; 29(2):231-243. PubMed ID: 30413906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice.
    Boitard SE; Marc Y; Keck M; Mougenot N; Agbulut O; Balavoine F; Llorens-Cortes C
    J Mol Cell Cardiol; 2019 Feb; 127():215-222. PubMed ID: 30599150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
    Borghi C; ; Rossi F;
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system and experimental heart failure.
    Wollert KC; Drexler H
    Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
    Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats.
    Yang K; Wang Y; Ding Y; Cui H; Zhou D; Chen L; Ma Z; Wang W; Zhang W; Luan J
    Chronobiol Int; 2019 Aug; 36(8):1058-1071. PubMed ID: 31096810
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems.
    Lee MA; Paul M; Böhm M; Ganten D
    Am J Cardiol; 1992 Oct; 70(10):12C-19C. PubMed ID: 1414888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renaissance of the renin-angiotensin system in the pathogenesis and therapy of arterial hypertension].
    Horký K
    Cas Lek Cesk; 1989 Sep; 128(37):1161-5. PubMed ID: 2805032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
    Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
    Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
    Ribeiro VT; de Souza LC; Simões E Silva AC
    Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake.
    Zhao X; White R; Van Huysse J; Leenen FH
    J Hypertens; 2000 Sep; 18(9):1319-26. PubMed ID: 10994763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.
    Wright JW; Mizutani S; Harding JW
    Heart Fail Rev; 2008 Sep; 13(3):367-75. PubMed ID: 17987382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
    Emdin M; Fatini C; Mirizzi G; Poletti R; Borrelli C; Prontera C; Latini R; Passino C; Clerico A; Vergaro G
    Clin Chim Acta; 2015 Mar; 443():85-93. PubMed ID: 25445411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control.
    Johnston CI
    J Hypertens Suppl; 1992 Dec; 10(7):S13-26. PubMed ID: 1337911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of brain renin angiotensin system in neurodegeneration: An update.
    Abiodun OA; Ola MS
    Saudi J Biol Sci; 2020 Mar; 27(3):905-912. PubMed ID: 32127770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of intracellular Ca2(+)-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats.
    Zolk O; Flesch M; Nickenig G; Schnabel P; Böhm M
    Cardiovasc Res; 1998 Jul; 39(1):242-56. PubMed ID: 9764204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
    Werner C; Baumhäkel M; Teo KK; Schmieder R; Mann J; Unger T; Yusuf S; Böhm M
    Clin Res Cardiol; 2008 Jul; 97(7):418-31. PubMed ID: 18454336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.